Navigation Links
Cynosure Reports Financial Results for the Fourth Quarter and Full Year 2008
Date:2/10/2009

GAAP financial measures in assessing Cynosure's performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to Cynosure's historical performance and our competitors' operating results. Cynosure believes that these non-GAAP measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making. Reconciliation of GAAP Income Statement Measures to Non-GAAP Income Statement Measures (Unaudited) -------------------------------------------------------------------- (In thousands, except per share data) Three Months Ended Year Ended December 31, December 31, 2008 2007 2008 2007 ---- ---- ---- ---- Gross profit $15,435 $24,101 $90,957 $79,808 ------- ------- ------- ------- Non-GAAP adjustments to gross profit: Stock-based compensation 127 104 537 373 --- --- --- --- Total non-GAAP adjustments to gross profit 127 104 537 373 --- --- --- --- Non-GAAP gross profit $15,562 $24,205 $91,494 $80,181 ======= ======= ======= ======= Three Months Ended Year Ended
'/>"/>
SOURCE Cynosure, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Cynosure to Announce Fourth-quarter and Full-year 2008 Financial Results on February 10
2. Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008
3. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
4. Cynosure to Announce Second-Quarter 2008 Financial Results on July 29
5. Cynosure President and CEO Michael Davin Named Ernst & Young Entrepreneur of the Year(R) 2008 Award Winner in New England
6. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
7. Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference
8. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
9. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
10. Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
11. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national president recruitment for Regional ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/3/2015)... ... 2015 , ... The Erie County Bar Association Institute of ... Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... these types of cases. , Each year, New York State residents are hospitalized ...
(Date:7/3/2015)... ... , ... Talcum powder attorneys representing clients in national lawsuits announce the launch ... website. Just as the previous version did, the new website will serve as a ... ovarian cancer warning information. The site is routinely updated with news articles on talcum ...
(Date:7/3/2015)... TX (PRWEB) , ... July 03, 2015 , ... ... the United States, named Mariah N. Manzanares, MD as the new Medical Director of ... new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at ... that he says will reveal biblical truth and expose popular lies regarding proper relationships ... Say Don’t Have Sex”, immediately goes into the core of the subject by explaining ...
Breaking Medicine News(10 mins):Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... , FRIDAY, Jan. 6 (HealthDay News) -- ... receive recommended care, a new study concludes. For ... diabetes patients who received medical care between 2005 and ... At these centers, free or reduced-cost care is provided ...
... (trade name: Zytiga) has been approved since September 2011 ... longer responsive to hormone therapy and progresses further during ... an early benefit assessment pursuant to the "Act on ... the German Institute for Quality and Efficiency in Health ...
... the progression of interstitial lung disease (ILD) in smokers, ... studies have suggested that statins might be beneficial in ... that they may contribute to the progression of pulmonary ... case reports have suggested that statins may contribute to ...
... , THURSDAY, Jan. 5 (HealthDay News) -- New research suggests ... expectant mothers the gender of their baby as early as the ... its kind, according to the South Korean researchers. They collected ... of pregnancy and concluded that various ratios of two enzymes called ...
... The new edition of America Speaks, a compilation of ... support for research and innovation to improve health, create ... Americans don,t believe we are making enough progress in ... the best health care system in the world. ...
... HealthDay Reporter , THURSDAY, Jan. 5 (HealthDay News) -- Man,s beloved ... humans, dogs can understand and anticipate the intentions of their ... were spoken to or who had direct eye contact with a ... moved across the room than if the person didn,t make direct ...
Cached Medicine News:Health News:Diabetes Care Thwarted by Unstable Health Insurance: Study 2Health News:Abiraterone: Indication of considerable added benefit in certain patients 2Health News:Statins may increase risk of interstitial lung abnormalities in smokers 2Health News:Blood Test May Reveal Child's Sex Soon After Conception 2Health News:Majority of Americans say research and development are key to building US economy 2Health News:Like Babies, Dogs Pick Up on People's Intent 2Health News:Like Babies, Dogs Pick Up on People's Intent 3
(Date:7/2/2015)... N.C. , July 2, 2015 ... assets related to the ion channel biology platform from ... been obtained as part of Pfizer,s 2011 acquisition of ... rights to the "Icagen" name and trademark.  XRPro Sciences ... services for ion channel and transporter drug discovery, combining ...
(Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
(Date:7/2/2015)... BGI gab heute bekannt, dass ... American College of Pathologists (CAP) akkreditiert wurde. ... klinische Next-Generation-Sequencing Labor, das in ... somit die höchsten Standards an klinischer Laborpraxis ... - 21 CFR Part 11 konformen Laborverfahren ...
Breaking Medicine Technology:Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
... Pharmaceuticals presented,positive results today from two phase ... on SPI-452, a novel pharmacokinetic enhancer (PKE) ... drug levels of,co-administered agents through inhibition of ... levels can lead to improved efficacy,reduced pill ...
... NIH-sponsored Clinical Trial to be Presented at Retrovirus ConferenceLEXINGTON, ... IDEV ) announced today that a National Institutes ... who received PRO 2000, the Company,s candidate vaginal microbicide ... of acquiring HIV infection than women who received a ...
Cached Medicine Technology:Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 2Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 3Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 4Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 5Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 2Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 3Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 4Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 5Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 6
Used after ablation to wash away particulate from anterior & posterior sides of flap & stromal bed. Conforms to the corneal flap. .0mm extension with a 11.0mm radius, Angled tip....
Smaller diameter wire probes & olive shape tips provide easier insertion through the lacrimal sac, 35cm (14 in) long, ID- .30mm (.012in); OD- .64mm (.025 in). S.S. Probes: .40mm x 11cm (27 G x 4 1/4...
...
...
Medicine Products: